CAMP4 Therapeutics Corporation (CAMP)
NASDAQ·Healthcare·Biotechnology
$3.92
+3.71%
Mkt Cap $94.31M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$10.75
Range $6.50 – $15.00
Implied Upside
+174.6%
Consensus $10.75 vs current $3.92
NASDAQ·Healthcare·Biotechnology
$3.92
+3.71%
Mkt Cap $94.31M
No recent rating data.
Price Target (7 analysts)
$10.75
Range $6.50 – $15.00
+174.6%
Consensus $10.75 vs current $3.92